OBJECTIVE: The pathophysiology of the lung fibrotic process in systemic sclerosis (SSc) is not fully elucidated. Since this pattern represents the leading cause of death in SSc, the knowledge of its actual pathophysiology is basic to prevent and stage pulmonary damage. In this study, we aimed to further investigate the relationship between the functional profiles of bronchoalveolar lavage (BAL) T cells and the pulmonary manifestation of the disease. METHODS: With this aim, we assessed the frequency of Th1, Th2 and Th17 producing T-lymphocytes and their effector cytokines in BAL of SSc patients without signs or symptoms of lung interstitial involvement (SScFib-) and with interstitial lung fibrosis (SScFib+). We also study as control group...
OBJECTIVES: Several studies have focused on the antifibrotic potential of the Th1 cytokine IFN-\u3...
OBJECTIVE: Lung involvement is the leading cause of morbidity and mortality in systemic sclerosis (...
OBJECTIVE: Lung involvement is the leading cause of morbidity and mortality in systemic sclerosis (...
AbstractPatients with scleroderma (systemic sclerosis—SSc) frequently develop an interstitial lung d...
BACKGROUND AND AIM: Fibrosing alveolitis develops in up to 80% of systemic sclerosis patients (SSc) ...
BACKGROUND AND AIM: Fibrosing alveolitis develops in up to 80% of systemic sclerosis patients (SSc) ...
Interstitial lung disease (ILD), which often develops in systemic sclerosis (SSc), is associated wit...
AbstractPatients with scleroderma (systemic sclerosis—SSc) frequently develop an interstitial lung d...
Interstitial lung disease (ILD), which often develops in systemic sclerosis (SSc), is associated wi...
Interstitial lung disease (ILD), which often develops in systemic sclerosis (SSc), is associated wi...
International audienceABSTRACT: INTRODUCTION: T cell abnormalities have been associated with the pat...
International audienceABSTRACT: INTRODUCTION: T cell abnormalities have been associated with the pat...
Background: Sarcoidosis is thought to be a T-helper type 1 cytokine (Th2 cytokine) mediated disorder...
This study was designed to investigate the levels of IL-2 and its soluble receptor (sIL-2R) in bronc...
OBJECTIVE: Lung involvement is the leading cause of morbidity and mortality in systemic sclerosis (S...
OBJECTIVES: Several studies have focused on the antifibrotic potential of the Th1 cytokine IFN-\u3...
OBJECTIVE: Lung involvement is the leading cause of morbidity and mortality in systemic sclerosis (...
OBJECTIVE: Lung involvement is the leading cause of morbidity and mortality in systemic sclerosis (...
AbstractPatients with scleroderma (systemic sclerosis—SSc) frequently develop an interstitial lung d...
BACKGROUND AND AIM: Fibrosing alveolitis develops in up to 80% of systemic sclerosis patients (SSc) ...
BACKGROUND AND AIM: Fibrosing alveolitis develops in up to 80% of systemic sclerosis patients (SSc) ...
Interstitial lung disease (ILD), which often develops in systemic sclerosis (SSc), is associated wit...
AbstractPatients with scleroderma (systemic sclerosis—SSc) frequently develop an interstitial lung d...
Interstitial lung disease (ILD), which often develops in systemic sclerosis (SSc), is associated wi...
Interstitial lung disease (ILD), which often develops in systemic sclerosis (SSc), is associated wi...
International audienceABSTRACT: INTRODUCTION: T cell abnormalities have been associated with the pat...
International audienceABSTRACT: INTRODUCTION: T cell abnormalities have been associated with the pat...
Background: Sarcoidosis is thought to be a T-helper type 1 cytokine (Th2 cytokine) mediated disorder...
This study was designed to investigate the levels of IL-2 and its soluble receptor (sIL-2R) in bronc...
OBJECTIVE: Lung involvement is the leading cause of morbidity and mortality in systemic sclerosis (S...
OBJECTIVES: Several studies have focused on the antifibrotic potential of the Th1 cytokine IFN-\u3...
OBJECTIVE: Lung involvement is the leading cause of morbidity and mortality in systemic sclerosis (...
OBJECTIVE: Lung involvement is the leading cause of morbidity and mortality in systemic sclerosis (...